Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Remote ischemic conditioning in STEMI, RIP

Key clinical point: Remote ischemic conditioning in patients undergoing primary percutaneous coronary intervention for ST-segment elevation MI is without clinical benefit.

Major finding: The primary composite endpoint of cardiac death or heart failure hospitalization at 12 months occurred in 9.4% of patients randomized to remote ischemic conditioning and 8.6% of standard-care controls.

Study details: This was a four-country, prospective, single-blind, randomized trial involving 5,401 patients undergoing primary percutaneous coronary intervention for ST-segment elevation MI.

Disclosures: The CONDI-2/ERIC-PPCI study was funded by the British Heart Foundation, University College London, the Danish Innovation Foundation, the Novo Nordisk Foundation, and TrygFonden.

Citation:

Bøtker HE. ESC 2019, Hot Line 2 session.